United States · Who invested in BAKX Therapeutics?
BAKX Therapeutics's investors include Sherpa Healthcare Partners.
United States · Series A startup
Who invested in BAKX Therapeutics
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2021, from 1 source
- Latest round
- Series A, $25MNov 2021
- Investors
- 1
The rounds
- Nov 2021
Founders and team
From the SEC filings it signed: 5 on the team.
- Ervis GavathiotisExecutive Officer, Promoteri
- Frances ToneguzzoPromoteri
- Jessie EnglishExecutive Officer, Promoteri
- Loren WalenskyExecutive Officer, Promoteri
- Sree KantExecutive Officer, Director, Promoteri
On the board, as filediPhillippe Lopes-FernandesYibing Shan
Quick answers about BAKX Therapeutics
How much has BAKX Therapeutics raised?
BAKX Therapeutics has raised $25M across 1 round since 2021.
When did BAKX Therapeutics last raise?
BAKX Therapeutics's most recent round was a Series A of $25M in Nov 2021.
What was BAKX Therapeutics's biggest round?
Its most recent round, $25M in Nov 2021, is also its largest on record.
Who backed BAKX Therapeutics first?
BAKX Therapeutics's first round on record, in Nov 2021, was backed by Sherpa Healthcare Partners.
What stage is BAKX Therapeutics at?
BAKX Therapeutics's latest named round is a Series A, in Nov 2021.
Where is BAKX Therapeutics based?
BAKX Therapeutics is based in the United States.
Companies like BAKX Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.